TrialPloS one2020

Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.

Dwight E Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.